0000-00-00 |
|
|
|
External link to document |
2021-04-13 |
1052 |
Post Trial Brief |
Invalidity of the Asserted Claims of U.S. Patent Nos. 7,144,884, 8,476,279, 9,090,575, 9,125,910 and 9,278,096…2018
28 October 2021
1:18-cv-00088
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2021-04-16 |
1061 |
Letter |
Noninfringement of U.S.
Patent Nos. 8,722,684, 9,125,626, 9,125,910, 9,278,096, and 9,…Brief on Noninfringement of U.S. Patent Nos.
8,722,684, 9,125,626, 9,125,910, 9,278,096…2018
28 October 2021
1:18-cv-00088
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2021-08-19 |
1073 |
Letter |
for finding induced
infringement of U.S. Patent No. 9,278,096 in this matter.
GSK II confirms that an…Defendants will induce infringement of
the ’096 Patent if approved, is consistent with GSK II and Federal…2018
28 October 2021
1:18-cv-00088
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2021-09-30 |
1076 |
Order |
U.S. Patent No.
7,144,884 ("the '884 Patent") and claims 5 and 15 of U.S . Patent No. …of
U.S. Patent No. 8,722,684 ("the '684 Patent"), claims 5-7 of U .S. Patent No. 9,861,630…63 0 Patent"), claims 4, 5, and 7 of U.S. Patent No. 9,278 ,096 ("the '096 Patent"…x27;684 Patent, claims 2-7 of the ' 630 Patent, claims 4, 5, and 7 of the '096 Patent, and claim…the
'684 Patent, claims 2-4 of the '630 Patent, claim 7 of the '096 Patent, and claim 6 |
External link to document |